The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

Documenti analoghi

• Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease
  di: Lucarotti, M. E., et al.
  Pubblicazione: (1991)
• Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
  di: Haglund, C., et al.
  Pubblicazione: (1989)
• Differentiating benign from malignant pancreatic cysts on computed tomography
  di: Yadav, Rajesh Kumar, et al.
  Pubblicazione: (2020)
• Differentiation of malignant from benign pancreatic mass by Tl-201 abdominal SPECT.
  di: Bom, H. S., et al.
  Pubblicazione: (1995)
• Biological Differentiation of Benign and Malignant Growths
  di: Greene, Harry S. N.
  Pubblicazione: (1944)